Insightec announces that the American Medical Association editorial panel approved their application for a new Category (Cat) I Current Procedural Terminology (CPT) code for MR-guided focused ultrasound ablation of neurological targets. This code will be added to the next CPT codebook and is set to become effective on Jan. 1, 2025.

“Achieving a Cat I CPT code is a tremendous milestone for not only Insightec, but for patients and physicians across the United States,” explains Maurice R. Ferré, MD, CEO, and chairman of the board of Insightec. “We’ve long known that focused ultrasound has a significant and valuable role in treating patients with neurological disorders. The approval of this code is further validation and indication of the broader adoption of focused ultrasound, and assurance that those who provide this critical service will receive consistent reimbursement.”

“This approval can also lead to expanded access to focused ultrasound for U.S. patients,” says Dee Kolanek, vice president of market access and reimbursement for Insightec. “Thanks to the American Association of Neurological Surgeons and the Congress of Neurological Surgeons who supported the application, this code now gives physicians a definitive reimbursement and, we believe, will have a positive impact on utilization going forward.” 

Focused ultrasound, which Insightec offers, is FDA-approved to treat essential tremor and Parkinsonian tremor. The procedure is performed in a single, outpatient procedure with many patients showing immediate improvement of tremor in the treated hand with minimal or no complications. There are currently over 50 treatment centers across the United States and more than 125 treatment centers around the world using Insightec’s Exablate Neuro platform.